[1] Papa S, Francavilla A, Paradies G, et al.The transport of pyruvate in rat liver mitochondria[J]. FEBS Letters, 1971, 12(5):285-288. [2] Halestrap AP.The mitochondrial pyruvate carrier. Kinetics and specificity for substrates and inhibitors[J]. Biochemical Journal, 1975, 148(1):85-96. [3] Brivet M, Garcia CAS, Dumez Y, et al.Impaired mitochondrial pyruvate importation in a patient and a fetus at risk[J]. Molecular Genetics & Metabolism, 2003, 78(3):186-192. [4] Bricker DK, Taylor EB, Schell JC, et al.A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans[J]. Science, 2012, 337(6090):96-100. [5] Herzig S, Martinou JC.Identification and functional expression of the mitochondrial pyruvate carrier[J]. Science, 2012, 337(6090):93-96. [6] Utter MF, Keech DB. Formation of oxaloacetate from pyruvate and carbon dioxide[J]. J Biol Chem, 1960, 235:PC17. [7] Vacanti NM, Divakaruni AS, Green CR, et al.Regulation of substrate utilization by the mitochondrial pyruvate carrier[J]. Molecular Cell, 2014, 56(3):425-435. [8] Vanderperre B, Herzig S, Krznar P, et al.Embryonic lethality of mitochondrial pyruvate carrier 1 deficient mouse can be rescued by a ketogenic diet[J]. PLoS Genetics, 2016, 12(5):e1006056. [9] Li X, Li Y, Han G, et al.Establishment of mitochondrial pyruvate carrier 1(MPC1)gene knockout mice with preliminary gene function analyses[J]. Oncotarget, 2016, 7(48):79981-79994. [10] Zou S, Lang T, Zhang B, et al.Fatty acid oxidation alleviates the energy deficiency caused by the loss of MPC1 in MPC1+/- mice[J]. Biochem Biophys Res Commun, 2018, 495(1):1008-1013. [11] Owen OE, Kalhan SC, Hanson RW.The key role of anaplerosis and cataplerosis for citric acid cycle function[J]. J Biol Chem, 2002, 277(34):30409-30412. [12] Vigueira PA, Mccommis KS, Schweitzer GG, et al.Mitochondrial pyruvate carrier 2 hypomorphism in mice leads to defects in glucose-stimulated insulin secretion[J]. Cell Reports, 2014, 7(6):2042-2053. [13] Gray LR, Sultana MR, Rauckhorst AJ, et al.Hepatic mitochondrial pyruvate carrier 1 is required for efficient regulation of gluconeogenesis and whole-body glucose homeostasis[J]. Cell Metabolism, 2015, 22(4):669-681. [14] Mccommis KS, Chen Z, Fu X, et al.Loss of mitochondrial pyruvate carrier 2 in liver leads to defects in gluconeogenesis and compensation via pyruvate-alanine cycling[J]. Cell Metabolism, 2015, 22(4):682-694. [15] Rauckhorst AJ, Gray LR, Sheldon RD, et al.The mitochondrial pyruvate carrier mediates high fat diet-induced increases in hepatic TCA cycle capacity[J]. Molecular Metabolism, 2017, 6(11):1468-1479. [16] Duan SZ, Ivashchenko CY, Russell MW, et al.Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-γ both induce cardiac hypertrophy in mice[J]. Circulation Research, 2005, 97(4):372-379. [17] Zhang H, Zhang A, Kohan DE, et al.Collecting duct-specific deletion of peroxisome proliferator-activated receptor γ blocks thiazolidinedione-induced fluid retention[J]. Proceedings of the National Academy of Sciences of the United States of America, 2005, 102(26):9406-9411. [18] Mccommis KS, Hodges WT, Brunt EM, et al.Targeting the mitochondrial pyruvate carrier attenuates fibrosis in a mouse model of nonalcoholic steatohepatitis[J]. Hepatology, 2017, 65(5):1543-1556. [19] Guan YF, Hao C, Cha DR, et al.Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption[J]. Nature Med, 2005, 11(8):861. [20] Chen Z, Vigueira PA, Chambers KT, et al.Insulin resistance and metabolic derangements in obese mice are ameliorated by a novel peroxisome proliferator-activated receptor γ-sparing thiazolidinedione[J]. J Biol Chem, 2012, 287(28):23537-23548. [21] Vigueira PA, Mccommis KS, Hodges WT, et al.The beneficial metabolic effects of insulin sensitizers are not attenuated by mitochondrial pyruvate carrier 2 hypomorphism[J]. Experimental Physiology, 2017, 102(8):985-999. [22] Vacanti NM, Divakaruni AS, Green CR, et al.Regulation of substrate utilization by the mitochondrial pyruvate carrier[J]. Molecular Cell, 2014, 56(3):425-435. [23] Colca JR, Mcdonald WG, Cavey GS, et al.Identification of a mitochondrial target of thiazolidinedione insulin sensitizers(mTOT)—relationship to newly identified mitochondrial pyruvate carrier proteins[J]. PLoS One, 2013, 8(5):e61551. [24] 赵凤艳, 屈艺, 张林, 等. Aurora A表达对人前列腺癌细胞生物学行为的影响[J]. 四川大学学报:医学版, 2007, 38(2):302-305. [25] Schell JC, Olson KA, Jiang L, et al.A role for the mitochondrial pyruvate carrier as a repressor of the warburg effect and colon cancer cell growth[J]. Molecular Cell, 2014, 56(3):400-413. [26] Cai H, Kumar N, Ai N, et al.Progenetix:12 years of oncogenomic data curation[J]. Nucleic Acids Research, 2014, 42(Database issue):1055-1062. [27] Aguirre-Gamboa R, Gomez-Rueda H, Martínez-Ledesma E, et al.SurvExpress:an online biomarker validation tool and database for cancer gene expression data using survival analysis[J]. PLoS One, 2013, 8(9):e74250. [28] Cerami E, Gao J, Dogrusoz U, et al.The cBio Cancer genomics portal:an open platform for exploring multidimensional cancer genomics data[J]. Cancer Discovery, 2012, 2(5):401-404. [29] Gao J, Aksoy BA, Dogrusoz U, et al.Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal[J]. Science Signaling, 2013, 6(269):pl1. [30] Network CGA.Comprehensive molecular characterization of human colon and rectal cancer[J]. Nature, 2012, 487(7407):330-337. [31] Handschin C, Spiegelman BM.Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism[J]. Endocrine Reviews, 2006, 27(7):728-735. [32] Girnun G.The diverse role of the PPARgamma coactivator 1 family of transcriptional coactivators in cancer[J]. Seminars in Cell & Developmental Biology, 2012, 23(4):381-388. [33] Koh E, Kim YK, Shin D, et al. MPC1 is essential for PGC-1α-induced mitochondrial respiration and biogenesis[J]. Biochemical Journal, 2018, 475(10):BCJ20170967. [34] 马向明. 线粒体丙酮酸载体与肝细胞肝癌患者预后的相关性研究[D]. 天津:天津医科大学, 2017. [35] Morrison R, Schleicher SM, Sun Y, et al.Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis[J]. Journal of Oncology, 2011(12):941876. [36] Heddleston JM, Li Z, Lathia JD, et al.Hypoxia inducible factors in cancer stem cells[J]. British Journal of Cancer, 2010, 102(5):789-795. [37] Defronzo RA, Abdul-Ghani M.Type 2 diabetes can be prevented with early pharmacological intervention[J]. Diabetes Care, 2011, 2(Suppl 2):202-209. [38] Ryder REJ.Pioglitazone:an agent which reduces stroke, myocardial infarction and death and is also a key component of the modern paradigm for the optimum management of type 2 diabetes[J]. British Journal of Diabetes & Vascular Disease, 2011, 11(3):113-120. [39] Corbet C, Bastien E, Draoui N, et al.Interruption of lactate uptake by inhibiting mitochondrial pyruvate transport unravels direct antitumor and radiosensitizing effects[J]. Nature Communications, 2018, 9(1):1208. |